FDA Inspection 954731 — Anna Sidorowicz-Bialynicka, M.D.
The FDA completed an inspection of Anna Sidorowicz-Bialynicka, M.D. on January 19, 2016 in Wroclaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 19, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wroclaw (Poland)
Additional Details
Clinical Investigator (CI)